BRF1(RNA聚合酶III转录复合体亚基)胚系突变与遗传性结直肠癌的关联
研究对一个无已知结直肠癌风险基因突变的高危家族中3例结直肠癌患者进行全外显子测序,筛选共享变异并在547例额外遗传性/早发性结直肠癌病例中验证。BRF1罕见胚系变异见于503个结直肠癌家族中的11个,显著高于对照人群的4300人中的34人。作者认为BRF1胚系突变与结直肠癌易感相关,有害BRF1变异与1.4%的家族性结直肠癌相关。
要点
- BRF1罕见胚系变异见于11/503个结直肠癌家族,显著高于对照的34/4300。
- 7个变异(其中1个见于2个家族)影响BRF1 mRNA剪接、蛋白稳定性或表达/功能。
- 有害BRF1变异与1.4%的家族性结直肠癌相关。
核心结论
- 在有结直肠癌家族史的家系分析中,作者将BRF1胚系突变与结直肠癌易感相关联。
- 作者报告有害BRF1变异与1.4%的家族性结直肠癌相关,这些个体无既往已知的高外显率基因突变。
- 作者认为该发现为调控核糖体合成的基因缺陷与结直肠癌风险之间的关联增添了额外证据。
研究设计与样本
- 对西班牙一个高结直肠癌风险家族中3例结直肠癌患者(诊断年龄分别为65、62、40岁)采集血样行全外显子测序。
- 筛选3例亲属共享的罕见错义、截短或剪接位点变异。
- 采用靶向混合DNA扩增联合下一代测序,在547例额外遗传性和/或早发性结直肠癌病例(502个额外家族)中筛查候选基因突变。
- 在HT29人结直肠癌细胞系中进行蛋白依赖性酵母生长实验和转染研究以检测所鉴定变异的作用。
主要发现
- 3例亲属共享38个基因中的42个独特或罕见(人群次要等位基因频率低于1%)非同义遗传变异。
- 基于所鉴定变异的预测效应及BRF1与癌症的既往关联,选择编码RNA聚合酶III转录起始因子亚基的BRF1基因进一步分析。
- BRF1中既往未报告或罕见的胚系变异见于503个结直肠癌家族中的11个,显著高于对照人群的4300人中的34人。
- 所鉴定的7个变异(其中1个在2个家族中检出)影响BRF1 mRNA剪接、蛋白稳定性或表达和/或功能。
关键数值与推荐
- 共享变异筛选标准:3例亲属共享的罕见错义、截短或剪接位点变异。
- BRF1变异频率:503个结直肠癌家族中11个检出,对照人群4300人中34个检出,家族性结直肠癌中占比1.4%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Although there is a genetic predisposition to colorectal cancer (CRC), few of the genes that affect risk have been identified. We performed whole-exome sequence analysis of individuals in a high-risk family without mutations in genes previously associated with CRC risk to identify variants associated with inherited CRC. METHODS: We collected blood samples from 3 relatives with CRC in Spain (65, 62, and 40 years old at diagnosis) and performed whole-exome sequence analyses. Rare missense, truncating or splice-site variants shared by the 3 relatives were selected. We used targeted pooled DNA amplification followed by next generation sequencing to screen for mutations in candidate genes in 547 additional hereditary and/or early-onset CRC cases (502 additional families). We carried out protein-dependent yeast growth assays and transfection studies in the HT29 human CRC cell line to test the effects of the identified variants. RESULTS: A total of 42 unique or rare (population minor allele frequency below 1%) nonsynonymous genetic variants in 38 genes were shared by all 3 relatives. We selected the BRF1 gene, which encodes an RNA polymerase III transcription initiation factor subunit for further analysis, based on the predicted effect of the identified variant and previous association of BRF1 with cancer. Previously unreported or rare germline variants in BRF1 were identified in 11 of 503 CRC families, a significantly greater proportion than in the control population (34 of 4300). Seven of the identified variants (1 detected in 2 families) affected BRF1 mRNA splicing, protein stability, or expression and/or function. CONCLUSIONS: In an analysis of families with a history of CRC, we associated germline mutations in BRF1 with predisposition to CRC. We associated deleterious BRF1 variants with 1.4% of familial CRC cases, in individuals without mutations in high-penetrance genes previously associated with CRC. Our findings add additional evidence to the link between defects in genes that regulate ribosome synthesis and risk of CRC.
引用
- Bellido F, Sowada N, Mur P, et al. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer. Gastroenterology. 2017. PMID: 28912018. doi:10.1053/j.gastro.2017.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。